Register entry
Pharmacyclics LLC
- Registered sites
- 0
- Drug products
- 6
- Live patents
- 448
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
448Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| IMBRUVICA | IBRUTINIB | Dec 2026 |
| IMBRUVICA | IBRUTINIB | Apr 2027 |
| IMBRUVICA | IBRUTINIB | Jun 2027 |
| IMBRUVICA | IBRUTINIB | Oct 2027 |
| IMBRUVICA | IBRUTINIB | Nov 2027 |
| IMBRUVICA | IBRUTINIB | May 2028 |
| IMBRUVICA | IBRUTINIB | Jun 2031 |
| IMBRUVICA | IBRUTINIB | Dec 2031 |
| IMBRUVICA | IBRUTINIB | Jun 2033 |
| IMBRUVICA | IBRUTINIB | Aug 2033 |
| IMBRUVICA | IBRUTINIB | Oct 2033 |
| IMBRUVICA | IBRUTINIB | Dec 2033 |
| IMBRUVICA | IBRUTINIB | Feb 2034 |
| IMBRUVICA | IBRUTINIB | Apr 2034 |
| IMBRUVICA | IBRUTINIB | Oct 2034 |
| IMBRUVICA | IBRUTINIB | Apr 2035 |
| IMBRUVICA | IBRUTINIB | Mar 2036 |
| IMBRUVICA | IBRUTINIB | Apr 2036 |
| IMBRUVICA | IBRUTINIB | Sept 2036 |
| IMBRUVICA | IBRUTINIB | Jun 2039 |
Catalogue
Marketed products
6Showing 6 of 6.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Imbruvica | Ibrutinib | SUSPENSION | NDA |
| Imbruvica | Ibrutinib | TABLET, FILM COATED | NDA |
| Imbruvica | Ibrutinib | CAPSULE | NDA |
| Imbruvica | Ibrutinib | CAPSULE | NDA |
| Imbruvica | Ibrutinib | TABLET, FILM COATED | NDA |
| Imbruvica | Ibrutinib | TABLET, FILM COATED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.